Marker Therapeutics, Inc. (MRKR)

1.83 -0.17 (-8.50%) USD  |  NASDAQ  |  Jan 12, 16:00
1.81 -0.02 (-1.09%) After-Hours: 05:29
More

Marker Therapeutics Non-Current Portion of Long Term Debt (Per Share Quarterly)

Non-Current Portion of Long Term Debt (Per Share Quarterly) Chart

View Non-Current Portion of Long Term Debt (Per Share Quarterly) for MRKR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Non-Current Portion of Long Term Debt (Per Share Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Non Current Portion of Debt Definition

View Non Current Portion of Debt Definition
Start Trial

Non-current portion of debt that a company owns. Think of this as a component of what a company has for debt that is not a short-term obligation.

Read full definition.

Non-Current Portion of Long Term Debt (Per Share Quarterly) Range, Past 5 Years

View Non-Current Portion of Long Term Debt (Per Share Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Non-Current Portion of Long Term Debt (Per Share Quarterly) Benchmarks

View Non-Current Portion of Long Term Debt (Per Share Quarterly) Benchmarks
Start Trial
ADMA Biologics, Inc. Upgrade
Viridian Therapeutics, Inc. Upgrade
Neurocrine Biosciences, Inc. Upgrade
Kiniksa Pharmaceuticals International Plc Upgrade
AIM ImmunoTech, Inc. Upgrade